AAAAAA

   
Results: 1-9 |
Results: 9
MONOCYTE AND GRANULOCYTE CD11B CD18, CD62L EXPRESSION AND SICAM-1 CONCENTRATION IN THE INTERDIALYTIC PERIOD/
Authors: THYLEN P FERNVIK E LUNDAHL J LINS LE JACOBSON SH
Citation: P. Thylen et al., MONOCYTE AND GRANULOCYTE CD11B CD18, CD62L EXPRESSION AND SICAM-1 CONCENTRATION IN THE INTERDIALYTIC PERIOD/, Nephron, 74(2), 1996, pp. 275-282
LONG-TERM EFFECTS OF ERYTHROPOIETIN TREATMENT ON THE COAGULATION SYSTEM DURING STANDARDIZED HEMODIALYSIS
Authors: CLYNE N LINS LE EGBERG N
Citation: N. Clyne et al., LONG-TERM EFFECTS OF ERYTHROPOIETIN TREATMENT ON THE COAGULATION SYSTEM DURING STANDARDIZED HEMODIALYSIS, Clinical nephrology, 43(4), 1995, pp. 260-267
EFFECTS OF HEMODIALYSIS AND LONG-TERM ERYTHROPOIETIN TREATMENT ON PROTEIN-C, AND ON FREE AND TOTAL PROTEIN-S
Authors: CLYNE N EGBERG N LINS LE
Citation: N. Clyne et al., EFFECTS OF HEMODIALYSIS AND LONG-TERM ERYTHROPOIETIN TREATMENT ON PROTEIN-C, AND ON FREE AND TOTAL PROTEIN-S, Thrombosis research, 80(2), 1995, pp. 161-168
HEMODIALYSIS INCREASES LEVELS OF PROTEIN-C, WHILE LONG-TERM ERYTHROPOIETIN TREATMENT DOES NOT AFFECT LEVELS OF ENDOGENOUS ANTICOAGULANTS
Authors: CLYNE N LINS LE EGBERG N
Citation: N. Clyne et al., HEMODIALYSIS INCREASES LEVELS OF PROTEIN-C, WHILE LONG-TERM ERYTHROPOIETIN TREATMENT DOES NOT AFFECT LEVELS OF ENDOGENOUS ANTICOAGULANTS, Journal of the American Society of Nephrology, 5(3), 1994, pp. 412-412
FLUCTUATION IN MONOCYTE AND GRANULOCYTE CD11B CD18 - CD62L EXPRESSIONAND SICAM-1 CONCENTRATION IN THE INTERDIALYTIC PERIOD/
Authors: THYLEN P FERNVIK E LINS LE LUNDAHL J JACOBSON SH
Citation: P. Thylen et al., FLUCTUATION IN MONOCYTE AND GRANULOCYTE CD11B CD18 - CD62L EXPRESSIONAND SICAM-1 CONCENTRATION IN THE INTERDIALYTIC PERIOD/, Journal of the American Society of Nephrology, 5(3), 1994, pp. 480-480
ACUTE SYMPTOMS DURING AND BETWEEN HEMODIALYSIS - THE RELATIVE ROLE OFSPEED, DURATION, AND BIOCOMPATIBILITY OF DIALYSIS
Authors: SKROEDER NR JACOBSON SH LINS LE KJELLSTRAND CM
Citation: Nr. Skroeder et al., ACUTE SYMPTOMS DURING AND BETWEEN HEMODIALYSIS - THE RELATIVE ROLE OFSPEED, DURATION, AND BIOCOMPATIBILITY OF DIALYSIS, Artificial organs, 18(12), 1994, pp. 880-887
PROGRESSIVE DECLINE IN RENAL-FUNCTION INDUCES A GRADUAL DECREASE IN TOTAL HEMOGLOBIN AND EXERCISE CAPACITY
Authors: CLYNE N JOGESTRAND T LINS LE PEHRSSON SK
Citation: N. Clyne et al., PROGRESSIVE DECLINE IN RENAL-FUNCTION INDUCES A GRADUAL DECREASE IN TOTAL HEMOGLOBIN AND EXERCISE CAPACITY, Nephron, 67(3), 1994, pp. 322-326
EFFICACY AND SAFETY OF MEXILETINE IN THE TREATMENT OF DIABETIC NEUROPATHY
Authors: OSKARSSON P FAGERBERG SE LJUNGGREN JG LINS LE LINS PE
Citation: P. Oskarsson et al., EFFICACY AND SAFETY OF MEXILETINE IN THE TREATMENT OF DIABETIC NEUROPATHY, Diabetologia, 37, 1994, pp. 10000177-10000177
THE INFLUENCE OF DIALYZER GEOMETRY ON BLOOD-COAGULATION AND BIOCOMPATIBILITY
Authors: LINS LE BOBERG U JACOBSON SH KJELLSTRAND C LJUNGBERG B SKRODER R
Citation: Le. Lins et al., THE INFLUENCE OF DIALYZER GEOMETRY ON BLOOD-COAGULATION AND BIOCOMPATIBILITY, Clinical nephrology, 40(5), 1993, pp. 281-285
Risultati: 1-9 |